Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9926 | 1043 | 48.2 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MIR 122 | Author keyword | 61 | 61% | 6% | 66 |
2 | MICRORNA 122 | Author keyword | 29 | 72% | 2% | 23 |
3 | MIR 224 | Author keyword | 4 | 34% | 1% | 10 |
4 | HOSP ZHENJIANG 3 | Address | 4 | 75% | 0% | 3 |
5 | HEPATOSIS | Address | 3 | 57% | 0% | 4 |
6 | LIVER DIS GUANGDONG PROV | Address | 3 | 57% | 0% | 4 |
7 | DIPARTIMENTO CHIRURG TR IANTI | Address | 3 | 100% | 0% | 3 |
8 | SERUM MIRNA | Author keyword | 3 | 42% | 0% | 5 |
9 | MIRNA 122 | Author keyword | 2 | 44% | 0% | 4 |
10 | BIOLOGICAL THERAPY OF CANCER | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MIR 122 | 61 | 61% | 6% | 66 | Search MIR+122 | Search MIR+122 |
2 | MICRORNA 122 | 29 | 72% | 2% | 23 | Search MICRORNA+122 | Search MICRORNA+122 |
3 | MIR 224 | 4 | 34% | 1% | 10 | Search MIR+224 | Search MIR+224 |
4 | SERUM MIRNA | 3 | 42% | 0% | 5 | Search SERUM+MIRNA | Search SERUM+MIRNA |
5 | MIRNA 122 | 2 | 44% | 0% | 4 | Search MIRNA+122 | Search MIRNA+122 |
6 | BIOLOGICAL THERAPY OF CANCER | 2 | 67% | 0% | 2 | Search BIOLOGICAL+THERAPY+OF+CANCER | Search BIOLOGICAL+THERAPY+OF+CANCER |
7 | MIRAVIRSEN | 2 | 67% | 0% | 2 | Search MIRAVIRSEN | Search MIRAVIRSEN |
8 | MIRNA PCR ARRAY | 2 | 67% | 0% | 2 | Search MIRNA+PCR+ARRAY | Search MIRNA+PCR+ARRAY |
9 | DIFFERENTIALLY EXPRESSED MIRNA | 1 | 38% | 0% | 3 | Search DIFFERENTIALLY+EXPRESSED+MIRNA | Search DIFFERENTIALLY+EXPRESSED+MIRNA |
10 | HBV RELATED HCC | 1 | 38% | 0% | 3 | Search HBV+RELATED+HCC | Search HBV+RELATED+HCC |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MIR 122 | 106 | 66% | 9% | 97 |
2 | LIVER SPECIFIC MICRORNA | 21 | 40% | 4% | 40 |
3 | NON TUMOROUS TISSUES | 18 | 49% | 2% | 26 |
4 | REGULATES G1 S TRANSITION | 15 | 88% | 1% | 7 |
5 | DOXORUBICIN SENSITIVITY | 15 | 73% | 1% | 11 |
6 | MIR 122 EXPRESSION | 13 | 80% | 1% | 8 |
7 | SUPPRESSES CELL PROLIFERATION | 5 | 55% | 1% | 6 |
8 | HUMAN HEPATOCARCINOMA CELLS | 5 | 25% | 2% | 16 |
9 | MICRORNA 122 | 4 | 39% | 1% | 9 |
10 | MICRORNA MIR 122 | 4 | 46% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
miR-122-A key factor and therapeutic target in liver disease | 2015 | 8 | 115 | 62% |
MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma? | 2013 | 72 | 40 | 70% |
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches | 2015 | 6 | 172 | 26% |
Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics | 2015 | 3 | 102 | 41% |
miRNA in hepatocellular carcinoma | 2015 | 2 | 129 | 55% |
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma | 2015 | 3 | 155 | 37% |
MicroRNAs in liver disease | 2013 | 57 | 129 | 51% |
Emerging role of microRNA in hepatocellular carcinoma | 2015 | 1 | 68 | 65% |
The role of microRNAs in liver cancer progression | 2011 | 88 | 48 | 67% |
Circulating microRNAs: Emerging Biomarkers of Liver Disease | 2015 | 1 | 85 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HOSP ZHENJIANG 3 | 4 | 75% | 0.3% | 3 |
2 | HEPATOSIS | 3 | 57% | 0.4% | 4 |
3 | LIVER DIS GUANGDONG PROV | 3 | 57% | 0.4% | 4 |
4 | DIPARTIMENTO CHIRURG TR IANTI | 3 | 100% | 0.3% | 3 |
5 | ENVIRONM GENETICALLY ASSOCIATED DIS | 2 | 67% | 0.2% | 2 |
6 | VACCINE INFECT DIS ORG VIDO | 2 | 67% | 0.2% | 2 |
7 | RIC BIOMED PL | 2 | 50% | 0.3% | 3 |
8 | LIVER CARCINOGENESIS SECT | 2 | 23% | 0.7% | 7 |
9 | BANK TUMOR OURCES | 2 | 43% | 0.3% | 3 |
10 | ABDOMINAL ONCOL 4 | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000213799 | MICRORNA//MIR 21//MICRORNAS |
2 | 0.0000194378 | MARC RUTI BELL VASC BIOL DIS PROGRAM//MIR 33//ABCA1 PROTEIN |
3 | 0.0000179675 | PHARMACOEPIGENETICS//ALFRED MED EDUC PROJECT//BANDUNG HOSP |
4 | 0.0000153917 | O I//VIRAL MICRORNAS//VIRAL MIRNA |
5 | 0.0000117306 | GW182//DROSHA//ARGONAUTE |
6 | 0.0000104865 | MIR 155//MIR 146A//MIRNA 155 |
7 | 0.0000102024 | MOL DIABET//GDD GED TOXICOL//HARVARD PROGRAM THER EUT SCI |
8 | 0.0000098297 | MIR 34A//MICRORNA 34A//MIR 34 |
9 | 0.0000096543 | MIR 196A2//RS2910164//RS11614913 |
10 | 0.0000093803 | NEUROTRAUMA VARIAT REGENERAT//TIANTAN HOSP//OTORHINOLARYNGOL MAXILLO IAL ONCOL |